Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-04 @ 9:39 PM
Study NCT ID:
NCT02997956
Status:
WITHDRAWN
Last Update Posted:
2017-04-25
First Post:
2016-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-07
Completion Date Type:
ESTIMATED
First Submit Date:
2016-12-16
First Submit QC Date:
None
Study First Post Date:
2016-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-21
Last Update Post Date:
2017-04-25
Last Update Post Date Type:
ACTUAL